Support a balanced approach to appetite, fat metabolism, and healthy body weight with a clinically studied, full-spectrum Calabrian bergamot ingredient developed for modern weight management and metabolic health formulations.
Healthy weight management is influenced by more than calorie intake alone. Appetite signaling, fat metabolism, insulin responsiveness, cellular energy production, and overall cardiometabolic function all contribute to how the body manages weight. Bergamonte® BPE-C brings these interconnected areas together through a pectin-enriched spectrum of Calabrian bergamot polyphenols evaluated in human research measuring body weight, BMI, appetite-related hormones, and metabolic markers.
Human Weight Management Research
Clinical research has directly measured body weight, BMI, and appetite-related hormones over a 90-day period.
Full-Spectrum BPE-C
The studied formulation combines standardized bergamot polyphenols with naturally occurring pectin and vitamin C.
Multiple Measured Markers
Research evaluated physical outcomes alongside leptin, ghrelin, adiponectin, glucose, and insulin-resistance measurements.
Dose-Responsive Study Design
Two daily intake levels were evaluated against placebo to assess how measured outcomes changed with dosage.
Sustainable weight management depends on the interaction of hunger cues, nutrient utilization, stored fat, and cellular energy pathways. Bergamonte® supports these related systems as part of a comprehensive metabolic wellness strategy.
Key Clinical Benefits
Appetite is influenced in part by hormones that communicate hunger, fullness, and energy availability. Human research on Bergamonte® BPE-C evaluated leptin, ghrelin, and adiponectin, providing a scientific foundation for formulas designed to support balanced appetite signaling and healthy eating patterns.
The body continually stores and mobilizes fat in response to energy needs. Bergamonte® polyphenols have been studied across pathways involving phosphodiesterase activity, AMPK activation, lipolysis, and liver lipid metabolism, helping support the body’s natural ability to process and utilize fats.
A 90-day human study of the pectin-enriched Bergamonte® BPE-C formulation measured changes in body weight and BMI at two daily intake levels. These findings support its use in products intended to complement healthy nutrition, regular physical activity, and a balanced lifestyle.
Clinical research across the Bergamonte® portfolio has examined body weight and BMI alongside metabolic and hormonal factors relevant to healthy weight management. The studies below show how different formulations have been evaluated across direct weight outcomes, BMI and the physiological signals that help shape the broader weight-management story.*
Why it matters: Direct human research showed dose-related changes in both weight and BMI.
Why it matters: Both clinically studied CitruSlim® intakes produced a significant BMI response versus placebo.
A 12-week randomized, double-blind, placebo-controlled study evaluated a formulation providing approximately 300 mg/day Bergacyn® + 300 mg/day BergaFlow™ in adults with hepatic steatosis. Body weight decreased by approximately 4.2 kg versus 2.7 kg with placebo, while BMI decreased by 1.6 versus 0.9.
Why it matters: The study connects healthy weight outcomes with a broader metabolic-health strategy.
The 90-day BPE-C study also evaluated hormones involved in energy balance. At 650 and 1,300 mg/day, leptin decreased by 12.3% and 21.36%, ghrelin decreased by 6.89% and 14.90%, and adiponectin increased by 18.65% and 21.76%, respectively. These changes occurred alongside the observed weight and BMI responses.
Why it matters: The research extends the weight story into metabolic signaling associated with energy balance.
Results reflect the specific formulations, intake levels, study populations and durations evaluated. Certain outcomes were observed with multi-ingredient or combination formulations and should not be attributed interchangeably across all Bergamonte® ingredients.
Weight-management formulation is increasingly shifting from aggressive stimulant strategies toward products that address appetite, metabolic function, energy utilization, and sustainable lifestyle support. Consumers are also looking for ingredients that can fit comfortably into everyday wellness routines rather than products built around short-term stimulation.
The pectin-enriched Bergamonte® formulation aligns naturally with that shift. Its research considers body weight and BMI alongside appetite-related hormones and cardiometabolic measurements, giving product developers a more complete platform for healthy weight-management positioning.
Bergamonte® provides a non-stimulant alternative to traditional weight-management ingredients, supported by a pectin-enriched formulation studied across weight, appetite, and metabolic markers.
Weight-management concepts within the Bergamonte® portfolio range from dedicated weight-focused formulations to ingredients that connect body weight with metabolic and liver health. This allows formulators to choose between a direct healthy-weight story and a broader metabolic approach.
let’s get started
Discuss your formulation goals, intended positioning, research needs, and product-development opportunities with the HP Ingredients team.
Schedule Now
Evaluate Bergamonte® for your next product concept with a sample for formulation, compatibility, and product-development testing.
Request Now
Ready to explore how Bergamonte® can support your product pipeline? Contact HP Ingredients for samples, technical documentation, clinical research, formulation guidance, and next-step support.
Contact Us